# FDA Grants First-Ever Authorization to a Generative AI Medical Device in 2026

> news · REPORTED · 2026-08-12

The FDA authorized its first medical device incorporating generative AI functionality in 2026, ending a gap dating back to the public availability of consumer-facing generative AI in November 2022. The milestone marks a significant regulatory shift that is expected to open the door to a new class of AI-assisted clinical decision support tools.

About FDA: The U.S. Food and Drug Administration is the federal regulatory agency responsible for approving and overseeing the safety and efficacy of drugs, biologics, and medical devices in the United States.

- Company: FDA
- Sector: medical devices
- Primary source: https://www.mintz.com/insights-center/viewpoints/2791/2026-08-12-fda-flux-august-2026-newsletter

---
Source: MedFuel Intel news monitor. Verification tier: REPORTED. Informational only, not investment advice. Corrections: media@medfuelinc.com.